Key result
The SARS-CoV-2 nucleocapsid protein inhibits UPF1 unwinding activity and disrupts the UPF1/UPF2 complex, evading host nonsense-mediated mRNA decay.
Why the study?
Viral infections often suppress nonsense-mediated mRNA decay by interfering with UPF1 to protect the viral genome, prompting investigation into the interplay between UPF1 and the SARS-CoV-2 nucleocapsid protein.
The SARS-CoV-2 nucleocapsid protein evades host defenses by disrupting the nonsense-mediated mRNA decay pathway through direct interference with UPF1 and UPF2.
Identifies Np-mediated NMD evasion in animal models; leaves open whether targeting Np-UPF interactions offers antiviral strategies in humans.
The nonsense-mediated mRNA decay (NMD) pathway triggers the degradation of defective mRNAs and governs the expression of mRNAs with specific characteristics. Current understanding indicates that NMD is often significantly suppressed during viral infections to protect the viral genome. In numerous viruses, this inhibition is achieved through direct or indirect interference with the RNA helicase UPF1, thereby promoting viral replication and enhancing pathogenesis. In this study, we employed biochemical, biophysical assays and cellular investigations to explore the interplay between UPF1 and the nucleocapsid (Np) protein of SARS-CoV-2. We evaluated their direct interaction and its impact on inhibiting cellular NMD. Furthermore, we characterized how this interaction affects UPF1's enzymatic function. Our findings demonstrate that Np inhibits the unwinding activity of UPF1 by physically obstructing its access to structured nucleic acid substrates. Additionally, we showed that Np binds directly to UPF2, disrupting the formation of the UPF1/UPF2 complex essential for NMD progression. Intriguingly, our research also uncovered a surprising pro-viral role of UPF1 and an antiviral function of UPF2. These results unveil a novel, multi-faceted mechanism by which SARS-CoV-2 evades the host's defenses and manipulates cellular components. This underscores the potential therapeutic strategy of targeting Np-UPF1/UPF2 interactions to treat COVID-19.
No takes yet. Share an insight, caveat, or question.
Nuccetelli et al. (2025) studied SARS-CoV-2 infection. SARS-CoV-2 nucleocapsid (Np) protein was evaluated on UPF1 enzymatic function and UPF1/UPF2 complex formation. The SARS-CoV-2 nucleocapsid protein inhibits UPF1 unwinding activity and disrupts the UPF1/UPF2 complex, evading host nonsense-mediated mRNA decay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: